Study of the UTMD-based delivery system to induce cervical cancer cell apoptosis and inhibit proliferation with shRNA targeting Survivin

International Journal of Molecular Sciences

Volumn 14, Issue 1, 2013, Pages 1763-1777

  Chen, Zhi Yi ^a   Liang, Kun ^a   Lin, Yan ^a   Yang, Feng ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Gene therapy; Microbubble; Non viral vector; RNA interference; Ultrasound

Indexed keywords

CASPASE 3; CD34 ANTIGEN; CYCLINE; KI 67 ANTIGEN; NUCLEAR PROTEIN; NUCLEOSTEMIN; PROTEIN BAX; PROTEIN BCL 2; SHORT HAIRPIN RNA; SURVIVIN; UNCLASSIFIED DRUG; BIRC5 PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CAPILLARY DENSITY; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG DELIVERY SYSTEM; EXPRESSION VECTOR; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INHIBITION KINETICS; MICROBUBBLE; MOUSE; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; RNA INTERFERENCE; TUMOR VOLUME; ULTRASOUND TARGETED MICROBUBBLE DESTRUCTION; UPREGULATION; UTERINE CERVIX CANCER; ANIMAL; BAGG ALBINO MOUSE; BLOOD VESSEL; DRUG SCREENING; GENE TRANSFER; GENETICS; HELA CELL LINE; METABOLISM; NUDE MOUSE; PATHOLOGY; RANDOMIZATION; ULTRASOUND; UTERINE CERVICAL NEOPLASMS;

MUS MUSCULUS;

ANIMALS; APOPTOSIS; BLOOD VESSELS; CASPASE 3; CELL PROLIFERATION; FEMALE; GENE TRANSFER TECHNIQUES; HELA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBITOR OF APOPTOSIS PROTEINS; KI-67 ANTIGEN; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROBUBBLES; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-BCL-2; RANDOM ALLOCATION; RNA INTERFERENCE; RNA, SMALL INTERFERING; TUMOR BURDEN; ULTRASONICS; UTERINE CERVICAL NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84878653057     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms14011763     Document Type: Article

References (31)

1. Davis, M.E.; Zuckerman, J.E.; Choi, C.H.; Seligson, D.; Tolcher, A.; Alabi, C. A,; Yen, Y.; Heidel, J.D.; Ribas, A. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 2010, 464, 1067-1070.
2. Rao, D.D.; Vorhies, J.S.; Senzer, N.; Nemunaitis, J. siRNA vs. shRNA: Similarities and differences. Adv. Drug Deliv. Rev. 2009, 61, 746-759.
3. Suzuki, J.; Ogawa, M.; Takayama, K.; Taniyama, Y.; Morishita, R.; Hirata, Y.; Nagai, R.; Isobe, M. Ultrasound-microbubble-mediated intercellular adhesion molecule-1 small interfering ribonucleic acid transfection attenuates neointimal formation after arterial injury in mice. J. Am. Coll. Cardiol. 2010, 55, 904-913.
4. Suzuki, R.; Oda, Y.; Utoguchi, N.; Maruyama, K. Progress in the development of ultrasound-mediated gene delivery systems utilizing nano-and microbubbles. J. Control. Release 2011, 149, 36-41.
5. Reslan, L.; Mestas, J.L.; Herveau, S.; Béra, J.C.; Dumontet, C. Transfection of cells in suspension by ultrasound cavitation. J. Control. Release 2010, 142, 251-258.
6. Chen, Z.Y.; Liang, K.; Xie, M.X.; Wang, X.F.; Lü, Q.; Zhang, J. Induced apoptosis with ultrasound-mediated microbubble destruction and shRNA targeting survivin in transplanted tumors. Adv. Ther. 2009, 26, 99-106.
7. Chen, Z.Y.; Liang, K.; Qiu, R.X. Targeted gene delivery in tumor xenografts by the combination of ultrasound-targeted microbubble destruction and polyethylenimine to inhibit survivin gene expression and induce apoptosis. J. Exp. Clin. Cancer Res. 2010, 29, 152.
8. Wang, J.; Zheng, Y.; Yang, F.; Zhao, P.; Li, H. Survivin small interfering RNA transfected with a microbubble and ultrasound exposure inducing apoptosis in ovarian carcinoma cells. Int. J. Gynecol. Cancer 2010, 20, 500-506.
9. Minchinton, A.I.; Tannock, I.F. Drug penetration in solid tumours. Nat. Rev. Cancer 2006, 6, 583-592.
10. Shariat, S.F.; Ashfaq, R.; Roehrborn, C.G.; Slawin, K.M.; Lotan, Y. Expression of survivin and apoptotic biomarkers in benign prostatic hyperplasia. J. Urol. 2005, 174, 2046-2050.
11. Hinnis, A.R.; Luckett, J.C.; Walker, R.A. Survivin is an independent predictor of short-term survival in poor prognostic breast cancer patients. Br. J. Cancer 2007, 96, 639-645.
12. Trojan, L.; Thomas, D.; Friedrich, D.; Grobholz, R.; Knoll, T.; Alken, P.; Michel, M.S. Expression of different vascular endothelial markers in prostate cancer and BPH tissue: An immunohistochemical and clinical evaluation. Anticancer Res. 2004, 24, 1651-1656.
13. Chen, Y.C.; Shen, S.C.; Lee, W.R.; Hsu, F.L.; Lin, H.Y.; Ko, C.H.; Tseng, S.W. Emodin induces apoptosis in human promyeloleukemic HL-60 cells accompanied by activation of caspase 3 cascade but independent of reactive oxygen species production. Biochem. Pharmacol. 2002, 64, 1713-1724.
14. Caldas, H.; Holloway, M.P.; Hall, B.M.; Qualman, S.J.; Altura, R.A. Survivin-directed RNA interference cocktail is a potent suppressor of tumour growth in vivo. J. Med. Genet. 2006, 43, 119-128.
15. Zhang, R.; Ma, L.; Zheng, M.; Ren, J.; Wang, T.; Meng, Y.; Zhao, J.; Jia, L.; Yao, L.; Han, H.; et al. Survivin knockdown by short hairpin RNA abrogates the growth of human hepatocellular carcinoma xenografts in nude mice. Cancer Gene. Ther. 2010, 17, 275-288.
16. McDonald, D.M.; Choyke, P.L. Imaging of angiogenesis: from microscope to clinic. Nat. Med. 2003, 9, 713-725.
17. Wang, Y.; Yuan, F. Delivery of viral vectors to tumor cells: Extracellular transport, systemic distribution, and strategies for improvement. Ann. Biomed. Eng. 2006, 34, 114-127.
18. McGuire, S.; Zaharoff, D.; Yuan, F. Nonlinear dependence of hydraulic conductivity on tissue deformation during intratumoral infusion. Ann. Biomed. Eng. 2006, 34, 1173-1181.
19. Shukla, G.S.; Krag, D.N. Selective delivery of therapeutic agents for the diagnosis and treatment of cancer. Expert. Opin. Biol. Ther. 2006, 6, 39-54.
20. Duvshani-Eshet, M.; Benny, O.; Morgenstern, A.; Machluf, M. Therapeutic ultrasound facilitates antiangiogenic gene delivery and inhibits prostate tumor growth. Mol. Cancer Ther. 2007, 6, 2371-2382.
21. Miller, D.L.; Pislaru, S.V.; Greenleaf, J.E. Sonoporation: Mechanical DNA delivery by ultrasonic cavitation. Somat. Cell. Mol. Genet. 2002, 27, 115-134.
22. Duvshani-Eshet, M.; Machluf, M. Therapeutic ultrasound optimization for gene delivery: A key factor achieving nuclear DNA localization. J. Control. Release 2005, 108, 513-528.
23. Tomizawa, M.; Ebara, M.; Saisho, H.; Sakiyama, S.; Tagawa, M. Irradiation with ultrasound of low output intensity increased chemosensitivity of subcutaneous solid tumors to an anti-cancer agent. Cancer Lett. 2001, 173, 31-35.
24. Nie, F.; Xu, H.X.; Lu, M.D.; Wang, Y.; Tang, Q. Anti-angiogenic gene therapy for hepatocellular carcinoma mediated by microbubble-enhanced ultrasound exposure: An in vivo experimental study. J. Drug Target. 2008, 16, 389-395.
25. Thompson, C.B. Apoptosis in the pathogenesis and treatment of disease. Science 1995, 267, 1456-1462.
26. Honda, H.; Zhao, Q.L.; Kondo, T. Effects of dissolved gases and an echo contrast agent on apoptosis induced by ultrasound and its mechanism via the mitochondria-caspase pathway. Ultrasound. Med. Biol. 2002, 28, 673-682.
27. Feril, L.B., Jr.; Kondo, T.; Zhao, Q.L.; Ogawa, R. Enhancement of hyperthermia-induced apoptosis by non-thermal effects of ultrasound. Cancer Lett. 2002, 178, 63-70.
28. Takeuchi, S.; Udagawa, Y.; Oku, Y.; Fujii, T. Nishimura H, Kawashima N: Basic study on apoptosis induction into cancer cells U-937 and EL-4 by ultrasound exposure. Ultrasonics 2006, 44, 345-348.
29. Niidome, T.; Huang, L. Gene therapy progress and prospects: Nonviral vectors. Gene. Ther. 2002, 9, 1647-1652.
30. Iwanaga, K.; Tominaga, K.; Yamamoto, K.; Habu, M.; Maeda, H.; Akifusa, S.; Tsujisawa, T.; Okinaga, T.; Fukuda, J. Nishihara T: Local delivery system of cytotoxic agents to tumors by focused sonoporation. Cancer Gene. Ther. 2007, 14, 354-363.
31. Nix, P.; Cawkwell, L.; Patmore, H. Greenman J and Stafford N: Bcl-2 expression predicts radiotherapy failure in laryngeal cancer. Br. J. Cancer 2005, 92, 2185-2189.